Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 11;9(4):1115-1118.
doi: 10.1016/j.ekir.2024.01.006. eCollection 2024 Apr.

Use of Avacopan in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Estimated Glomerular Filtration Rate <15 ml/min per 1.73 m2

Bryce Barr  1 , Kim Cheema  2 , Aurore Fifi-Mah  2 , Stephanie Garner  2 , Louis-Philippe Girard  2
Affiliations

Use of Avacopan in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Estimated Glomerular Filtration Rate <15 ml/min per 1.73 m2

Bryce Barr et al. Kidney Int Rep. .
No abstract available

Keywords: avacopan; glomerulonephritis; vasculitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical course of patients treated with avacopan.∗Avacopan initiated. #Prednisone discontinued
See this image and copyright information in PMC

References

    1. de Joode A.A.E., Sanders J.S.F., Stegeman C.A. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol. 2013;8:1709–1717. doi: 10.2215/CJN.01020113. - DOI - PMC - PubMed
    1. Jayne D.R.W., Merkel P.A., Schall T.J., Bekker P., ADVOCATE Study Group Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med. 2021;384:599–609. doi: 10.1056/nejmoa2023386. - DOI - PubMed
    1. Cortazar F.B., Niles J.L., Jayne D.R.W., et al. Renal recovery for patients with ANCA-associated vasculitis and low eGFR in the ADVOCATE trial of avacopan. Kidney Int Rep. 2023;8:860–870. doi: 10.1016/j.ekir.2023.01.039. - DOI - PMC - PubMed
    1. Cortazar F.B., Cerda J., Dhanani R., Roglieri J., Santoriello D. Avacopan in patients with rapidly progressive glomerulonephritis requiring dialysis. Kidney Int Rep. 2023;8:1687–1691. doi: 10.1016/j.ekir.2023.05.017. - DOI - PMC - PubMed
    1. de Groot K., Harper L., Jayne D.R.W., Felipe L., Suarez F., Gregorini G. Pulse versus Daily Oral cyclophosphamide for induction of remission in antineutrophil antibody. Ann Intern Med. 2009;150:670–680. doi: 10.7326/0003-4819-150-10-200905190-00004. - DOI - PubMed

LinkOut - more resources